379 related articles for article (PubMed ID: 10599711)
1. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
Johannsson G; Albertsson-Wikland K; Bengtsson BA
J Clin Endocrinol Metab; 1999 Dec; 84(12):4516-24. PubMed ID: 10599711
[TBL] [Abstract][Full Text] [Related]
2. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
[TBL] [Abstract][Full Text] [Related]
3. What happens when growth hormone is discontinued at completion of growth? Metabolic aspects.
Johannsson G
J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1321-6. PubMed ID: 11202204
[TBL] [Abstract][Full Text] [Related]
4. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group.
Attanasio AF; Lamberts SW; Matranga AM; Birkett MA; Bates PC; Valk NK; Hilsted J; Bengtsson BA; Strasburger CJ
J Clin Endocrinol Metab; 1997 Jan; 82(1):82-8. PubMed ID: 8989238
[TBL] [Abstract][Full Text] [Related]
5. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents.
Fors H; Bjarnason R; Wirént L; Albertsson-Wikland K; Bosaeust L; Bengtsson BA; Johannsson G
Clin Endocrinol (Oxf); 2001 Nov; 55(5):617-24. PubMed ID: 11894973
[TBL] [Abstract][Full Text] [Related]
6. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
[TBL] [Abstract][Full Text] [Related]
7. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.
Bengtsson BA; Abs R; Bennmarker H; Monson JP; Feldt-Rasmussen U; Hernberg-Stahl E; Westberg B; Wilton P; Wüster C
J Clin Endocrinol Metab; 1999 Nov; 84(11):3929-35. PubMed ID: 10566630
[TBL] [Abstract][Full Text] [Related]
8. Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults.
Svensson J; Fowelin J; Landin K; Bengtsson BA; Johansson JO
J Clin Endocrinol Metab; 2002 May; 87(5):2121-7. PubMed ID: 11994351
[TBL] [Abstract][Full Text] [Related]
9. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.
Colao A; di Somma C; Pivonello R; Cuocolo A; Spinelli L; Bonaduce D; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2002 Mar; 87(3):1088-93. PubMed ID: 11889170
[TBL] [Abstract][Full Text] [Related]
10. Baseline characteristics and the effects of two years of growth hormone (GH) replacement therapy in adults with GH deficiency previously treated for acromegaly.
Norrman LL; Johannsson G; Sunnerhagen KS; Svensson J
J Clin Endocrinol Metab; 2008 Jul; 93(7):2531-8. PubMed ID: 18397981
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
[TBL] [Abstract][Full Text] [Related]
12. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
Cuneo RC; Judd S; Wallace JD; Perry-Keene D; Burger H; Lim-Tio S; Strauss B; Stockigt J; Topliss D; Alford F; Hew L; Bode H; Conway A; Handelsman D; Dunn S; Boyages S; Cheung NW; Hurley D
J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
[TBL] [Abstract][Full Text] [Related]
13. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
Abs R; Feldt-Rasmussen U; Mattsson AF; Monson JP; Bengtsson BA; Góth MI; Wilton P; Koltowska-Häggström M
Eur J Endocrinol; 2006 Jul; 155(1):79-90. PubMed ID: 16793953
[TBL] [Abstract][Full Text] [Related]
14. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
Sas T; Mulder P; Hokken-Koelega A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
[TBL] [Abstract][Full Text] [Related]
15. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study.
Underwood LE; Attie KM; Baptista J;
J Clin Endocrinol Metab; 2003 Nov; 88(11):5273-80. PubMed ID: 14602761
[TBL] [Abstract][Full Text] [Related]
17. The cardiovascular risk of GH-deficient adolescents.
Colao A; Di Somma C; Salerno M; Spinelli L; Orio F; Lombardi G
J Clin Endocrinol Metab; 2002 Aug; 87(8):3650-5. PubMed ID: 12161490
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults.
Pfeifer M; Verhovec R; Zizek B; Prezelj J; Poredos P; Clayton RN
J Clin Endocrinol Metab; 1999 Feb; 84(2):453-7. PubMed ID: 10022400
[TBL] [Abstract][Full Text] [Related]
19. The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency.
Colao A; Cerbone G; Pivonello R; Aimaretti G; Loche S; Di Somma C; Faggiano A; Corneli G; Ghigo E; Lombardi G
J Clin Endocrinol Metab; 1999 Apr; 84(4):1277-82. PubMed ID: 10199767
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
Link K; Moëll C; Garwicz S; Cavallin-Ståhl E; Björk J; Thilén U; Ahrén B; Erfurth EM
J Clin Endocrinol Metab; 2004 Oct; 89(10):5003-12. PubMed ID: 15472198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
